Currently, there are limited supplies of the reagents used for HIV-1 Western Blot and HIV-2 EIA testing. In order to conserve the remaining reagent, a controlled process of batch testing was implemented. Therefore, you will likely see additional delays in receiving these supplemental test results.
Read about our plan to mitigate this on the Communications page by clicking this link: Communications
Reminder - Dr. Buff Mair is the new CTS Medical Director. Several of the CTS client forms specify li...
CTS successfully implemented Donor-Screen HLA® Class I and II testing on the Stratec Biomedical ...
On July 6, 2018 the FDA released an industry guidance document for transitioning from individual to ...
CTS originally communicated that Tampa will convert from the current Grifols Ultrio Plus NAT triplex...
The new Learning Center website launch today on Monday, March 30, 2020. While the link to the new Le...
As a friendly reminder, airlines often change their routine flights and cargo hours for hol...